Lipids: Update on Diagnosis and Management of Dyslipidemia, An Issue of Endocrinology and Metabolism Clinics of North America
- 1st Edition, Volume 51-3 - August 17, 2022
- Latest edition
- Editors: Connie B. Newman, Alan Chait
- Language: English
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Connie B. Newman and Alan Chait bring their considerable expertise to the topic of… Read more
Purchase options
Description
Description
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Connie B. Newman and Alan Chait bring their considerable expertise to the topic of Lipids: Update on Diagnosis and Management of Dyslipidemia. When untreated, dyslipidemia may have serious comorbidities; in this issue, top experts cover the evaluation and management of LDL cholesterol and high triglicerides in adults and children, providing practical information that will help physicians and other health care professionals treat their patients and improve outcomes.
Key features
Key features
-
Contains 13 practice-oriented topics including lipid and lipoprotein metabolism; measurement of lipids and advanced lipid testing; assessment of CVD risk; inherited forms of hypercholesterolemia; new and emerging therapies for dyslipidemia; and more.
-
Provides in-depth clinical reviews on diagnosis and management of dyslipidemia, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Table of contents
Table of contents
Lipid and Lipoprotein Metabolism
Lipoprotein Assessment in the twenty-first Century
Assessment of Cardiovascular Disease Risk: A 2022 Update
The Inherited Hypercholesterolemias
Hypertriglyceridemia
High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand?
Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents
Management of Dyslipidemia in Endocrine Diseases
Dyslipidemia in Diabetes: When and How to Treat?
Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease
New and Emerging Therapies for Dyslipidemia
Safety of Statins and Nonstatins for Treatment of Dyslipidemia
LDL Cholesterol—How Low Can We Go?
Lipoprotein Assessment in the twenty-first Century
Assessment of Cardiovascular Disease Risk: A 2022 Update
The Inherited Hypercholesterolemias
Hypertriglyceridemia
High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand?
Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents
Management of Dyslipidemia in Endocrine Diseases
Dyslipidemia in Diabetes: When and How to Treat?
Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease
New and Emerging Therapies for Dyslipidemia
Safety of Statins and Nonstatins for Treatment of Dyslipidemia
LDL Cholesterol—How Low Can We Go?
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 51-3
- Published: August 17, 2022
- Language: English
About the editors
About the editors
CN
Connie B. Newman
Adjunct Professor of Medicine at the New York University Grossman School of Medicine, is Board Certified in Internal Medicine, Endocrinology and Metabolism, and Obesity Medicine. She is a Fellow of the American College of Physicians, the American Heart Association, the American Medical Women’s Association (AMWA), and the New York Academy of Medicine. She served as the 2018-2019 President of AMWA, an organization of women physicians, pre-medical and medical students that advocates for advancement of women in medicine, health equity and sex and gender based medical education. Dr. Newman is recognized for her expertise in hypercholesterolemia, hypertriglyceridemia, statin safety, and randomized controlled clinical trials. She is the Chair of the 2020 Endocrine Society clinical practice guideline on the management of dyslipidemia in endocrine diseases, and served as Chair of the writing group for the American Heart Association’s 2019 Scientific Statement on the safety of statins. Dr. Newman is an appointed member of the FDA Endocrine and Metabolic Disorders Advisory Committee. Dr. Newman writes and speaks on the topics of sex and gender health, high cholesterol and heart disease, and statin safety. She is the recipient of the 2020 Bertha Van Hoosen Award, named for the founder of AMWA. She is featured in “20 Women, 20 Years”, an online exhibit of leaders in the medical profession, sponsored by the Women in Medicine Legacy Foundation.
Affiliations and expertise
Adjunct Professor, Department of Medicine, Holman Division of Endocrinology, Diabetes and Metabolism, NYU Grossman School of Medicine, New York, USAAC
Alan Chait
Affiliations and expertise
Professor Emeritus, Medicine , Division of Metabolism, Endocrinology and Nutrition , University of Washington